{"disease":{"id":"chronic-myeloid-leukemia-accelerated-phase","name":"chronic myeloid leukemia accelerated phase"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06453902","title":"TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Shenzhen TargetRx Co., Ltd.","has_results":false},{"nct_id":"NCT05376852","title":"Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT01914484","title":"Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University Health Network, Toronto","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}